Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jul 5;200(1):107-13.
doi: 10.1084/jem.20040196. Epub 2004 Jun 28.

Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response

Affiliations

Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response

Simona Saccani et al. J Exp Med. .

Abstract

Transcription factors of the nuclear factor (NF)-kappaB/Rel family translocate into the nucleus upon degradation of the IkappaBs. Postinduction repression of NF-kappaB activity depends on NF-kappaB-regulated resynthesis of IkappaBalpha, which dissociates NF-kappaB from DNA and exports it to the cytosol. We found that after activation, p65/RelA is degraded by the proteasome in the nucleus and in a DNA binding-dependent manner. If proteasome activity is blocked, NF-kappaB is not promptly removed from some target genes in spite of IkappaBalpha resynthesis and sustained transcription occurs. These results indicate that proteasomal degradation of p65/RelA does not merely regulate its stability and abundance, but also actively promotes transcriptional termination.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Termination of the NF-κB response in IκBα-deficient cells. (A) Kinetics of NF-κB down-regulation in WT and IκBα−/− 3T3 cells. Cells were stimulated with TNF-α as indicated and analyzed for NF-κB binding activity by electrophoretic mobility shift assay (EMSA) using a canonical κB site as a probe (5′-AGTTGAGGGGACTTTCCCAGGC-3′). Data were quantified with a phosphorimager. Kinetics of IκBα degradation and resynthesis are also shown. (B) Proteasome inhibition prevents NF-κB down-regulation in IκBα−/− cells. After TNF-α washout, cells were incubated with β lactone and assayed by EMSA. An anti-p65 Western blot (W.B.) on cytoplasmic and nuclear extracts is shown. (C) Endogenous p65 is ubiquitinated after NF-κB activation. Extracts from IκBα−/− cells were immunoprecipitated with an anti-p65 antibody and blotted with an anti-ubiquitin monoclonal antibody. H.C., heavy chains. (D) Reconstitution of p65 ubiquitination by cotransfection of FLAG-p65 and myc-ubiquitin expression vectors in HEK-293T cells. Blots obtained from whole cell extracts were probed with an anti-p65 polyclonal antibody and an anti-myc monoclonal antibody. (E) IκBα−/− cells were stimulated with TNF for 15 min, washed, and incubated with 10 ng/ml LMB for an additional 3.15 h. EMSAs were performed on nuclear lysates. As a positive control for LMB effects, accumulation of IκB kinase complex α in the nuclear fraction of LMB-treated cells is shown.
Figure 2.
Figure 2.
p65 ubiquitination requires sequence-specific binding to κB sites. (A) WT p65 and a p65 mutant bearing a double substitution in the Rel homology domain (23Y > A; 26E > D) were cloned with an NH2-terminal GFP tag and transfected in HEK-293 cells alone or with a p50 expression vector. Total lysates were made and assayed by EMSA using a canonical κB site as a probe. The GFP tag allows easy discrimination between p65 homodimers and p65/p50 heterodimers (n.s., nonspecific). An anti-p65 immunoblot shows the expression of endogenous p65 and transfected GFP-p65 in total lysates. Expression of IκBα is also shown. (B) Association of WT and mutant GFP-p65 with p50 and IκBα. 293T cells were transfected as indicated. Total cell extracts were immunoprecipitated with either an anti-p50 or an anti-IκBα antibody and then blotted with an anti-p65 antibody. (C) The κB site binding-deficient p65 mutant is not efficiently polyubiquitinated. HEK-293T were cotransfected with the indicated expression vectors. Whole cell extracts were assayed for the appearance of high molecular weight ubiquitinated forms of p65 by anti-p65 immunoblotting. (D) p65 induces recruitment of proteasome components to target genes. HEK-293 cells were transfected with empty vector or a FLAG-p65 expression vector. ChIP assays with an anti-FLAG antibody, an antibody against Sug1, or a control antibody were performed. Recruitment of FLAG-p65 and Sug1 to the endogenous IκBα gene promoter is shown. (E) Anti-p65 and anti-Sug1 ChIP assays on HEK-293 cells stimulated with TNF-α. Immunoprecipitated DNA was amplified with primers spanning the IκBα promoter or a region immediately downstream of the IκBα gene.
Figure 3.
Figure 3.
Proteasome inhibition in IκBα-deficient cells determines persistent promoter occupancy and increased NF-κB–dependent transcriptional activity. (A) Anti-p65 ChIP in TNF-α–stimulated IκBα−/− cells. β lactone treatment after a pulse of TNF prolongs occupancy of all target genes tested and induces (B) increased and sustained transcription. (C) Proteasome inhibition increases κB site–directed transcription of a luciferase reporter in TNF-α–stimulated IκBα−/− cells.
Figure 4.
Figure 4.
Effects of proteasome inhibition on NF-κB response termination in IκBα-containing cells. (A) Proteasome inhibition impairs down-regulation of nuclear NF-κB activity (assayed by EMSA) in WT 3T3 cells. IκBα degradation and resynthesis is also shown. (B) Anti-p65 ChIP assay and mRNA analysis (C) in TNF-stimulated WT 3T3 cells treated with β lactone or vehicle as indicated. The effects of β lactone treatment on IP-10 and MIP-2 occupancy by p65 and on their transcriptional activity are shown. (D) Effects of proteasome inhibition on NF-κB response down-regulation and p65 occupancy of target genes (E) in NIH3T3 cells.

References

    1. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 10:405–455. - PubMed
    1. Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9:2723–2735. - PubMed
    1. Baldwin, A.S., Jr. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649–683. - PubMed
    1. Whiteside, S.T., and A. Israel. 1997. I kappa B proteins: structure, function and regulation. Semin. Cancer Biol. 8:75–82. - PubMed
    1. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18:621–663. - PubMed

Publication types